Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind ...
Jan 12, 2012
0
0
Prostate cancer is a leading cause of death from cancer in the US and especially in the Philadelphia region. Consistently, Philadelphia has outpaced the state of PA and the nation in diagnoses and death from prostate cancer. ...
Jun 10, 2020
0
7
Researchers at Jefferson's Maternal Addiction Treatment Education & Research (MATER) program found significant improvement in the quality of parenting among mothers who participated in a trauma-informed, mindfulness-based ...
Jul 27, 2017
0
99
A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine to prevent and reverse congestive heart failure is on the verge of clinical trials, after years of proving itself ...
Jul 20, 2011
0
0
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based ...
Jan 25, 2012
0
0
Malfunctioning mitochondria—the power plants in cells—are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, ...
Mar 9, 2016
1
154
Lead exposure in early childhood can lead to severe cognitive and behavioral impairments in children that last well into adolescence and adulthood. Although researchers have looked at effects of early life lead exposure on ...
Jul 25, 2022
0
68
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that strikes nearly 5,000 people in the U.S. every year. About 10% of ALS cases are inherited or familial, often caused ...
Jun 16, 2021
0
7
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme ...
Aug 10, 2011
0
0
Our skin tells us when we've spent too much time in the sun or when the dry air of winter has sucked away too much moisture. Now Jefferson researchers find that the skin can also foretell issues unrelated to the protective ...
Dec 10, 2020
0
63
